Navigation Links
Colorcon Acquires Pharmaceutical Excipient Company - NP Pharm
Date:4/22/2010

HARLEYSVILLE, Pa., April 22 /PRNewswire/ -- Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm.  This acquisition expands Colorcon's global excipient product offerings in the pharmaceutical and nutritional markets.

The addition of NP Pharm SUGLETS® sugar spheres complements Colorcon's SureSpheres® sugar spheres product line and barrier membrane systems for multiparticulates.  Colorcon will now have two production facilities for sugar spheres offering critical business continuity planning for their customer base.  ETHISPHERES® microcrystalline cellulose pellets, NPTAB® neutral pellets for direct compression, and other excipient products are also added to the Colorcon product portfolio as a result of this acquisition.

The headquarters and main production facilities of NP Pharm, located in Bazainville, France, will become an integral part of the Colorcon network of manufacturing sites.

William Motzer, Colorcon Chief Executive Officer states, "We are excited about this opportunity to expand Colorcon's product offerings and leverage our global distribution, technical service and sales infrastructure."

Newly appointed Chairman and CEO of the Management Board of Ethypharm, Hugues Lecat states, "We are delighted to see NP Pharm join Colorcon, Inc.  The new shareholder will permit NP Pharm to reinforce its development and growth projects.  This divestiture will enable us to go on investing in the growth of Ethypharm, in line with our strategy.  Ethypharm will continue to invest in its R&D sites, notably that of Grand Quevilly, France, our most recent state-of-the-art manufacturing plant, in which we have invested over 15 million Euros over the last two years."

About Colorcon, Inc.

Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our value-added services, which support all phases of solid oral dose design and development.

About Ethypharm

Ethypharm is one of the leading pharmaceutical companies dedicated to the development of innovative medicines.  Its patented technologies offer multiple benefits for patients by improving efficacy, administration, compliance, and reducing side-effects. Ethypharm provides its clients with solutions for the life cycle management of their drugs. The company has one of the broadest portfolios of technologies to become the worldwide privileged partner of pharmaceutical companies. Ethypharm offers customized solutions for the development of the medicines of the future.


'/>"/>
SOURCE Colorcon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
2. Perrigo Acquires Infant Formula Manufacturer PBM Holdings for $808 Million
3. Cambrex Acquires IEP GmbH
4. Essilor Acquires FGX International, Becoming a Major Player in a New Fast-Growing Market
5. Johns Hopkins Medicine Acquires Naviscan PEM Technology for Novel Radiotracer Research
6. Bioniche Pharma Acquires Seven New Products From GeneraMedix Inc.
7. STD Med Inc. Acquires Facility for Manufacturing and Start-Ups
8. PSKW & Associates LLC Acquires Triax Media, Licenses Triax to Subsidiary, Centricity Group
9. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
10. Advanced Health Media Acquires Advogent
11. VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and ... 2015 through 2022. Also, a six-year historic analysis is provided for these ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly ... announced plans to invest $850 million in its ... facilities across its U.S. enterprise, including research laboratories, ... investments are being driven by demand for Lilly ... potential medicines in development targeting cancer, pain, diabetes ...
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, ... advanced medical technology for non-invasive surgery, announced today ... System for treatment of uterine fibroids throughout the ... had received approval from the US Food and ... the Mirabilis System in the United States.  The ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... ... 2017 , ... “Finding Christ Through Social Media: Year One ... the writer’s path toward true communion with God. “Finding Christ Through Social Media: ... creation of published author Lea Michelle Johnson, a follower of Christ, wife and ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of ... people of God in congregations across the United States. “The Communion of ... in 1964 who has served congregations in seven states throughout his long career ...
(Date:3/23/2017)... ... 23, 2017 , ... A recent report from the National Council on Teacher ... NCTQ report suggests, based on a review of GPA and SAT/ACT requirements at 221 ... the U.S. It argues that this higher bar should be set by states, by ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) ... Road in Building 2. The clinic is the group’s second in New Braunfels and ... the company’s second New Braunfels location brings things full circle for the group, “It’s ...
Breaking Medicine News(10 mins):